The pathology of human spinal cord injury: defining the problems

J Neurotrauma. 2004 Apr;21(4):429-40. doi: 10.1089/089771504323004575.

Abstract

This article reviews the pathology of human spinal cord injury (SCI), focusing on potential differences between humans and experimental animals, as well as on aspects that may have mechanistic or therapeutic relevance. Importance is placed on astrocyte and microglial reactions. These cells carry out a myriad of functions and we review the evidence that supports their beneficial or detrimental effects. Likewise, vascular responses and the role of inflammation and demyelination in the mechanism of SCI are reviewed. Lastly, schwannosis is discussed, highlighting its high frequency and potential role when designing therapeutic interventions. We anticipate that a better understanding of the pathological responses in the human will be useful to investigators in their studies on the pathogenesis and therapy of SCI.

Publication types

  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Demyelinating Diseases / etiology
  • Demyelinating Diseases / pathology
  • Demyelinating Diseases / physiopathology
  • Disease Models, Animal
  • Disease Progression
  • Gliosis / physiopathology*
  • Gliosis / prevention & control
  • Humans
  • Myelitis / etiology
  • Myelitis / pathology
  • Myelitis / physiopathology
  • Schwann Cells / cytology
  • Schwann Cells / physiology
  • Spinal Cord / blood supply
  • Spinal Cord / pathology*
  • Spinal Cord / physiopathology
  • Spinal Cord Injuries / pathology*
  • Spinal Cord Injuries / physiopathology